Trial Profile
The impact of subcutaneous glucagon before, during and after exercise. A study in patients with type 1 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2017
Price :
$35
*
At a glance
- Drugs Glucagon (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 23 Jul 2017 Status changed from recruiting to completed.
- 03 Oct 2016 New trial record